Redx Pharma PLC operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Redx Pharma PLC with three other companies in this sector in UNITED KINGDOM : Fusion Antibodies PLC (2020 sales of £3.90 million [US$5.35 million] ), Silence Therapeutics Plc (£5.48 million [US$7.53 million] ), and Reneuron Group PLC (£6.07 million [US$8.33 million] of which 100% was Development of cell-based therapies).

Sales Analysis.